Use access key #2 to skip to page content.
$36.11 1.76 (5.12%)
7/8/2008 4:02 PM

Forest Laboratories, Inc. (FRX)

CAPS Rating:
****

The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating FRX

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

238 Outperforms
21 Underperforms
 

All-Stars

68 Outperforms
5 Underperforms
 

Wall Street

13 Outperforms
1 Underperforms
 

Players bullish on FRX are also bullish on:

Players bearish on FRX are also bearish on:

Ticker Tags

S&P 500 (482), Large Cap (467), Drug Manufacturers - Other (105)
Suggest a tag

Forest Laboratories, Inc. At A Glance

Current Price: $36.11
Last Trade Time: 7/8/2008 4:02 PM
Open: $0.00
Previous Close: $36.11
Daily Range: $34.30 - $36.25
52-Week Range: $31.75 - $47.53
Volume: 3,540,318
Market Cap: $11.00B
P/E Ratio: 11.72
Compare Our Special Broker Offers!

Stock Trends

FRX VS S&P 500 (SPY)

FRX 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for FRX

More Headlines...

Top Bull Pitch

Recs

1

Forest Laboratories, Inc. (FRX)

Avatar Bricktopp (< 20) Submitted: 4/01/08 12:08 PM

As a pharmacist I can tell you generic suppliers offer substantial discounts to pharmacies to use their products in preference to the Brands. Some of that is passed on to patients but a larger percent is retained by the pharmacy.





Generic companies with a large range of the m...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 40 :   1 2 3 4 5 Next »

Recs

0

 (FRX)

Avatar biovestor (36.68) Submitted: 6/28/08 3:54 PM : Outperform Start Price: $33.38 FRX Score: 8.75

A mid-size specialty pharma company around $10 billion market cap also set to gain from potential approval of milnacipran by end of October 2007 for fibromyalgia (with partner Cypress Bio). Company's products focus mainly on neuro indications such as depression and Alzheimer's with a forward PE below 10.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FRX)

Avatar joshnix2 (< 20) Submitted: 6/19/08 9:38 AM : Outperform Start Price: $32.18 FRX Score: 17.32

Good ROIC numbers, Haven't calculated the WACC but if someone does let me know what you come up with.


YPEG = $82.9389/share


and PEG = .95 suggesting a fairly valued stock.





The only problem I see is the uncertainty of Pharma with the election coming up.





I will keep this stock and see where it lands in August.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FRX)

Avatar Guffrey (99.03) Submitted: 6/16/08 11:09 AM : Outperform Start Price: $32.70 FRX Score: 17.09

Near 52-week low, despite high ROE and growth expectations, low D/E. Good entry point

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FRX)

Avatar hansthered0 (< 20) Submitted: 6/15/08 1:08 PM : Outperform Start Price: $35.38 FRX Score: 11.20

Magic Scouter

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FRX)

Avatar Frenchyx (98.82) Submitted: 6/14/08 11:44 AM : Outperform Start Price: $32.61 FRX Score: 17.41

No debt.
Lots of cash per share.
Excellent long term performance.
price metrics are attractive.
industry is out of favor.

It will be very interesting to see how FRX performs vs. PFE (Pfizer), at a 10 year low, yielding almost 8% now.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 40 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 14 of 14  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackLazardCapit 66.26 04/16/08 04/16/08 Outperform NS $35.51+1.69%-4.99%+6.68
TrackDreman 94.71 12/31/07 12/31/07 Outperform NS $36.45-0.93%-13.00%+12.07 Toggle the visibility of 60-Second Pitch and replies
TrackRothCapital < 20 12/24/07 12/24/07 Outperform NS $36.70-1.61%-14.53%+12.92
TrackSoleil 25.77 12/18/07 12/18/07 Outperform NS $37.40-3.45%-12.94%+9.49
TrackAmTech 31.31 11/26/07 11/26/07 Outperform NS $36.80-1.87%-11.33%+9.46
TrackEdwardOwens 98.61 09/30/07 09/30/07 Outperform NS $37.29-3.16%-16.63%+13.47 Toggle the visibility of 60-Second Pitch and replies
TrackJefferies 90.36 09/06/07 09/06/07 Outperform NS $41.90-13.82%-14.03%+0.21
TrackPacificGrow 56.32 07/23/07 07/23/07 Outperform NS $44.50-18.85%-17.53%-1.33
TrackUBS 96.39 07/11/07 07/11/07 Outperform NS $47.30-23.66%-15.62%-8.04
TrackFirstAlbany 76.93 05/23/07 05/23/07 Outperform NS $56.64-36.25%-16.84%-19.41
TrackMatrix 90.16 11/20/06 11/20/06 Outperform NS $48.50-25.55%-9.30%-16.24
TrackLehmanBros 88.18 10/16/06 10/16/06 Outperform NS $52.65-31.42%-6.82%-24.59
TrackSusquehanna < 20 08/17/06 08/17/06 Outperform NS $47.25-23.58%-1.12%-22.46
TrackJimCramer 83.15 06/05/06 06/05/06 Underperform 3W $37.43-3.53%+0.50%+4.03

Results 1 - 14 of 14  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners